Charles Schwab
TRVI icon

Charles Schwab’s Trevi Therapeutics TRVI Stock Holding History

Charles Schwab’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10M Buy
840,572
+3,772
+0.5% +$42.2K ﹤0.01% 2091
2025
Q4 		$10.5M Buy
836,800
+30,469
+4% +$352K ﹤0.01% 2120
2025
Q3 		$7.38M Buy
806,331
+580,396
+257% +$4.35M ﹤0.01% 2266
2025
Q2 		$1.24M Buy
225,935
+18,417
+9% +$115K ﹤0.01% 2832
2025
Q1 		$1.31M Buy
207,518
+34,455
+20% +$164K ﹤0.01% 2752
2024
Q4 		$713K Buy
173,063
+22,145
+15% +$70.9K ﹤0.01% 3033
2024
Q3 		$504K Hold
150,918
– – ﹤0.01% 3162
2024
Q2 		$450K Buy
150,918
+43,211
+40% +$120K ﹤0.01% 3243
2024
Q1 		$372K Hold
107,707
– – ﹤0.01% 3130
2023
Q4 		$144K Hold
107,707
– – ﹤0.01% 3314
2023
Q3 		$235K Hold
107,707
– – ﹤0.01% 3258
2023
Q2 		$257K Buy
107,707
+95,150
+758% +$240K ﹤0.01% 3265
2023
Q1 		$23.2K Hold
12,557
– – ﹤0.01% 3488
2022
Q4 		$24.2K Hold
12,557
– – ﹤0.01% 3479
2022
Q3 		$20K Hold
12,557
– – ﹤0.01% 3478
2022
Q2 		$36K Buy
+12,557
New +$30.8K ﹤0.01% 3440

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return